Baird Medical Investment Holdings Ltd
BDMD1.170USD
-0.040-3.31%
Close 11/05, 16:00（ET）Quotes delayed by 15 min
29.90MMarket Cap
LossP/E TTM
More Details of Baird Medical Investment Holdings Ltd Company
Baird Medical Investment Holdings Ltd is a company mainly engaged in the microwave ablation medical device business. The Company is mainly engaged in the provision of microwave ablation medical device. The medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps.
Baird Medical Investment Holdings Ltd Info
Ticker SymbolBDMD
Company nameBaird Medical Investment Holdings Ltd
IPO dateDec 13, 2021
CEOMr. Joe Ragan
Number of employees143
Security typeOrdinary Share
Fiscal year-endDec 13
AddressRoom 202, 2/F, Baide Building, Building 11, No.15, Rongtong Street, Yuexiu District
CityGUANGZHOU
Stock exchangeNASDAQ Capital Market Consolidated
CountryChina
Postal code- -
Phone
Websitehttps://ir.bairdmed.com/
Ticker SymbolBDMD
IPO dateDec 13, 2021
CEOMr. Joe Ragan
Company Executives of Baird Medical Investment Holdings Ltd
Name
Name/Position
Position
Shareholding
Change
Ms. Haimei Wu
Ms. Haimei Wu
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
18.30M
--
Mr. Joe Ragan
Mr. Joe Ragan
Director
Director
--
--
Prof. Mingzhao (Michael) Xing
Prof. Mingzhao (Michael) Xing
Independent Director
Independent Director
--
--
Mr. Lijian Xu
Mr. Lijian Xu
Independent Director
Independent Director
--
--
Mr. Rongjian Lu
Mr. Rongjian Lu
Chief Technology Officer, Deputy General Manager
Chief Technology Officer, Deputy General Manager
--
--
Ms. Jie Li
Ms. Jie Li
Acting Chief Financial Officer
Acting Chief Financial Officer
--
--
Mr. Wei Hou
Mr. Wei Hou
Director
Director
--
--
Mr. Jin Xu
Mr. Jin Xu
Quality Assurance Department Manager
Quality Assurance Department Manager
--
--
Mr. Wei Xu
Mr. Wei Xu
Merchandising Department Manager
Merchandising Department Manager
--
--
Mr. Robin Yang
Mr. Robin Yang
Investor Relations
Investor Relations
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Ms. Haimei Wu
Ms. Haimei Wu
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
18.30M
--
Mr. Joe Ragan
Mr. Joe Ragan
Director
Director
--
--
Prof. Mingzhao (Michael) Xing
Prof. Mingzhao (Michael) Xing
Independent Director
Independent Director
--
--
Mr. Lijian Xu
Mr. Lijian Xu
Independent Director
Independent Director
--
--
Mr. Rongjian Lu
Mr. Rongjian Lu
Chief Technology Officer, Deputy General Manager
Chief Technology Officer, Deputy General Manager
--
--
Ms. Jie Li
Ms. Jie Li
Acting Chief Financial Officer
Acting Chief Financial Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2024
FY2023
By BusinessUSD
Name
Revenue
Proportion
MWA Needles
33.83M
91.33%
MWA Therapeutic Apparatus
3.20M
8.64%
Other Medical Devices
9.83K
0.03%
By RegionUSD
Name
Revenue
Proportion
China (Mainland)
37.04M
100.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
MWA Needles
33.83M
91.33%
MWA Therapeutic Apparatus
3.20M
8.64%
Other Medical Devices
9.83K
0.03%
Shareholding Stats
Updated: Sun, Nov 2
Updated: Sun, Nov 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Wu (Haimei)
71.59%
ExcelFin SPAC LLC
18.68%
Grand Fortune Capital (H.K.) Co, Ltd.
9.65%
Periscope Capital
0.49%
Highbridge Capital Management, LLC
0.49%
Shareholders
Shareholders
Proportion
Wu (Haimei)
71.59%
ExcelFin SPAC LLC
18.68%
Grand Fortune Capital (H.K.) Co, Ltd.
9.65%
Periscope Capital
0.49%
Highbridge Capital Management, LLC
0.49%
Shareholder Types
Shareholders
Proportion
Individual Investor
71.59%
Corporation
28.32%
Investment Advisor/Hedge Fund
0.79%
Investment Advisor
0.53%
Hedge Fund
0.49%
Research Firm
0.29%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
45
538.38K
2.11%
-4.07M
2025Q2
48
25.90M
101.35%
+14.65M
2025Q1
81
6.17M
89.94%
-16.81M
2024Q4
86
6.26M
24.13%
-18.81M
2024Q3
89
6.01M
23.82%
-19.60M
2024Q2
91
6.99M
95.36%
-19.67M
2024Q1
95
7.38M
92.34%
-14.39M
2023Q4
94
1.73M
21.20%
-21.42M
2023Q3
93
4.65M
96.02%
-18.05M
2023Q2
90
5.14M
97.70%
-22.44M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Wu (Haimei)
18.30M
71.59%
+18.30M
--
May 13, 2025
ExcelFin SPAC LLC
4.77M
18.68%
-976.59K
-16.98%
May 13, 2025
Grand Fortune Capital (H.K.) Co, Ltd.
2.46M
9.65%
+2.46M
--
May 13, 2025
Periscope Capital
125.00K
0.49%
--
--
Jun 30, 2025
Highbridge Capital Management, LLC
125.00K
0.49%
--
--
Jun 30, 2025
UBS Financial Services, Inc.
91.45K
0.36%
+34.51K
+60.61%
Jun 30, 2025
Northern Trust Investments, Inc.
52.44K
0.21%
+52.44K
--
Jun 30, 2025
Susquehanna International Group, LLP
44.67K
0.17%
+44.67K
--
Jun 30, 2025
Jane Street Capital, L.L.C.
38.84K
0.15%
+38.84K
--
Jun 30, 2025
Virtu Americas LLC
26.36K
0.1%
+26.36K
--
Jun 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
